Midazolam



Indications and Reactions:

Role Indications Reactions
Primary
Product Used For Unknown Indication 17.3%
Sedation 15.1%
Foetal Exposure During Pregnancy 14.7%
Status Epilepticus 6.8%
Anaesthesia 6.5%
General Anaesthesia 5.4%
Induction Of Anaesthesia 4.7%
Tonic Convulsion 4.7%
Anaesthesia Procedure 4.3%
Epilepsy 2.9%
Analgesic Therapy 2.5%
Drug Detoxification 2.2%
Sedative Therapy 2.2%
Surgery 2.2%
Convulsion 1.8%
Anaesthetic Premedication 1.4%
Epidural Anaesthesia 1.4%
Pneumonia 1.4%
Spinal Anaesthesia 1.4%
Agitation 1.1%
Anaphylactic Reaction 10.2%
Hypotension 10.2%
Drug Ineffective 6.1%
Sedation 6.1%
Slow Response To Stimuli 6.1%
Agitation 4.1%
Amnesia 4.1%
Cardiac Arrest 4.1%
Delirium 4.1%
Drug Effect Decreased 4.1%
Drug Interaction 4.1%
Dystonia 4.1%
Eye Abscess 4.1%
Foetal Growth Restriction 4.1%
Hypersensitivity 4.1%
Obstructive Airways Disorder 4.1%
Oxygen Saturation Decreased 4.1%
Product Quality Issue 4.1%
Respiratory Depression 4.1%
Seizure Like Phenomena 4.1%
Secondary
Product Used For Unknown Indication 35.0%
Anaesthesia 12.2%
Status Epilepticus 7.6%
Sedation 7.4%
Drug Abuse 6.3%
Convulsion 5.0%
General Anaesthesia 4.4%
Induction Of Anaesthesia 3.4%
Epilepsy 2.5%
Analgesic Therapy 2.0%
Intentional Overdose 1.9%
Grand Mal Convulsion 1.7%
Hypertension 1.7%
Drug Exposure Via Mother 1.5%
Drug Use For Unknown Indication 1.5%
Anaesthesia Procedure 1.3%
Maternal Exposure Timing Unspecified 1.3%
Pain 1.2%
Ill-defined Disorder 1.1%
Infection 1.1%
Cognitive Disorder 10.7%
Drug Rash With Eosinophilia And Systemic Symptoms 10.0%
Drug Ineffective 8.2%
Status Epilepticus 6.1%
Tachycardia 5.7%
Toxicity To Various Agents 5.4%
Death 4.6%
Dementia Alzheimer's Type 4.6%
Drug Abuse 4.6%
Wrong Technique In Drug Usage Process 4.3%
Hypotension 3.9%
Respiratory Failure 3.9%
Toxic Epidermal Necrolysis 3.9%
Unresponsive To Stimuli 3.9%
Circulatory Collapse 3.6%
Premature Baby 3.6%
Anaphylactic Reaction 3.2%
Renal Failure 3.2%
Sedation 3.2%
Shock 3.2%
Concomitant
Product Used For Unknown Indication 47.5%
Prophylaxis 5.3%
Sedation 5.0%
Pain 4.5%
Anaesthesia 4.2%
Drug Use For Unknown Indication 4.0%
Induction Of Anaesthesia 3.0%
Status Epilepticus 2.9%
Premedication 2.7%
Sepsis 2.7%
Hypertension 2.5%
Nausea 2.2%
Electrolyte Substitution Therapy 1.9%
Coronary Artery Bypass 1.9%
Analgesic Therapy 1.9%
Epilepsy 1.6%
Maintenance Of Anaesthesia 1.6%
Surgery 1.5%
Constipation 1.5%
Sedative Therapy 1.5%
Thrombocytopenia 8.9%
Pain 7.5%
Sepsis 7.3%
Injury 5.6%
Serotonin Syndrome 5.6%
Death 5.2%
Hearing Impaired 5.2%
Hypotension 5.2%
Renal Failure 4.9%
Respiratory Failure 4.9%
Unevaluable Event 4.9%
Rhabdomyolysis 4.5%
Pulmonary Embolism 4.2%
Renal Failure Acute 4.2%
Gastrointestinal Haemorrhage 3.8%
Renal Impairment 3.8%
Vomiting 3.8%
Cardiac Arrest 3.5%
Drug Interaction 3.5%
Loss Of Consciousness 3.5%
Interacting
Product Used For Unknown Indication 20.6%
Restlessness 12.6%
Anaesthesia Procedure 11.9%
Induction Of Anaesthesia 9.8%
Abdominal Pain 8.4%
Sedative Therapy 5.2%
Spinal Anaesthesia 4.9%
Hypertension 4.2%
Tachycardia 3.5%
Antibiotic Prophylaxis 2.4%
Ill-defined Disorder 2.4%
Sedation 2.4%
Anaesthesia 1.7%
Dyspnoea 1.7%
Hallucination 1.7%
Maintenance Of Anaesthesia 1.7%
Depression 1.4%
Delirium 1.0%
Hiv Infection 1.0%
Parkinson's Disease 1.0%
Drug Interaction 26.8%
Myoclonus 19.5%
Cardiac Arrest 9.8%
Atrioventricular Dissociation 7.3%
Sedation 7.3%
Inhibitory Drug Interaction 4.9%
Coma 2.4%
Confusional State 2.4%
Hepatic Enzyme Increased 2.4%
Hypoxia 2.4%
Multiple Drug Overdose 2.4%
Overdose 2.4%
Peripheral Motor Neuropathy 2.4%
Renal Failure 2.4%
Respiratory Distress 2.4%
Toxicity To Various Agents 2.4%